Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Kemp

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Advances in Therapy|August 12, 2011
A shift in the treatment of hormone receptor and human epidermal growth factor receptor 2-positive metastatic breast cancerZoe Kemp, Alison Jones
JAMA|May 4, 2021
Surgery for Breast Cancer PreventionIsmail Jatoi, Zoe Kemp
JAMA|May 4, 2021
Risk-Reducing MastectomyIsmail Jatoi, Zoe Kemp
Human Molecular Genetics|September 11, 2004
An update on the genetics of colorectal cancerZoe Kemp, Cristina Thirlwell, Oliver Sieber, et al.
Journal of Medical Genetics|September 13, 2019
Germline <i>BRCA1</i> and <i>BRCA2</i> testing for breast cancer survivorsJennifer Wiggins, Anne McLoughlin, Angela George, et al.
Clinical Breast Cancer|December 2, 2017
Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening ProgrammeTerri P McVeigh, Jennifer Wiggins, Simon Ward, et al.
Breast (Edinburgh, Scotland)|December 28, 2022
Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?Quratul Ain, Caroline Richardson, Miriam Mutebi, et al.
Journal of Medical Genetics|October 29, 2025
Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meetingJoseph Christopher, Katharine Edgerley, Beth McIldowie, et al.
Clinical Medicine (London, England)|January 25, 2023
Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologistsRippie K Tutika, James A Bennett, Jean Abraham, et al.
Cancer Research|December 17, 2005
CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instabilityZoe Kemp, Andrew Rowan, William Chambers, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Advances in Therapy|August 12, 2011
A shift in the treatment of hormone receptor and human epidermal growth factor receptor 2-positive metastatic breast cancerZoe Kemp, Alison Jones
JAMA|May 4, 2021
Surgery for Breast Cancer PreventionIsmail Jatoi, Zoe Kemp
JAMA|May 4, 2021
Risk-Reducing MastectomyIsmail Jatoi, Zoe Kemp
Human Molecular Genetics|September 11, 2004
An update on the genetics of colorectal cancerZoe Kemp, Cristina Thirlwell, Oliver Sieber, et al.
Journal of Medical Genetics|September 13, 2019
Germline <i>BRCA1</i> and <i>BRCA2</i> testing for breast cancer survivorsJennifer Wiggins, Anne McLoughlin, Angela George, et al.
Clinical Breast Cancer|December 2, 2017
Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening ProgrammeTerri P McVeigh, Jennifer Wiggins, Simon Ward, et al.
Breast (Edinburgh, Scotland)|December 28, 2022
Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?Quratul Ain, Caroline Richardson, Miriam Mutebi, et al.
Journal of Medical Genetics|October 29, 2025
Recontact and follow-up for individuals with germline pathogenic variants in hereditary breast and ovarian cancer susceptibility genes: a UK Cancer Genetics Group consensus meetingJoseph Christopher, Katharine Edgerley, Beth McIldowie, et al.
Clinical Medicine (London, England)|January 25, 2023
Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologistsRippie K Tutika, James A Bennett, Jean Abraham, et al.
Cancer Research|December 17, 2005
CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instabilityZoe Kemp, Andrew Rowan, William Chambers, et al.
Pageof 4